Two-Dose Intranasal NSC-EV Therapy Reduced Aged Hippocampal Inflammation in Mice
TL;DR: A 2026 mouse study in Journal of Extracellular Vesicles found that two intranasal doses of hiPSC-NSC-EVs reduced inflammatory pathway markers in the aged hippocampus and were associated with better memory performance. Key Findings Two-dose nasal treatment: Late middle-aged 18-month-old male and female C57BL/6J mice received two intranasal doses of hiPSC-NSC-EVs before assessment in old …
